STOCK TITAN

Domo and Regional One Health Named 2023 Nucleus ROI Award Winners

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
Regional One Health achieves 190% ROI with Domo's data experience platform
Positive
  • Regional One Health achieved a total ROI of 190% through the adoption of Domo's platform
  • Streamlining care practices and improving patient outcomes led to a decrease in patient length of stay and harmful events
  • Creation of pharmacy billing and collections databases with Domo helped cut expenses by $100,000 annually and double revenue capture rate
Negative
  • None.

Regional One Health sees 190% ROI with a payback period of 1.2 years after deploying Domo

SILICON SLOPES, Utah--(BUSINESS WIRE)-- Domo (Nasdaq: DOMO) announced today that it and Regional One Health, a national leader in healthcare, received a Nucleus Research ROI Award for achieving a total ROI of 190% through the adoption of Domo’s data experience platform. The platform enabled significant improvements in patient care, advanced operational efficiencies and revenue for Regional One Health.

As a premier healthcare organization, Regional One Health aims to transform the way it delivers healthcare through informed, data-driven decisions. In collaboration with Domo, the team at Regional One worked with physicians and nurses to identify the data they rely on most when making decisions about care, such as length of stay and patient satisfaction, and leverage the Domo platform to track progress towards key goals.

“As one of the busiest trauma centers in the country, we need to be efficient about how we drive improvement. Our physicians use evidence-based medicine to treat patients, so it only makes sense that physician leaders and administrators need to make evidence-based health care delivery decisions,” said Kito Lord, MD, MBA, Senior Medical Director and Physician Advisor at Regional One Health. “Domo takes complex information and helps simplify it, giving us the evidence we need through real-time data to drive innovation, make better decisions, and improve patient outcomes.”

Using Domo, Regional One Health was able to streamline care practices through data visualizations, reduce patient length of stay at the center, improve patient access to prescriptions and decrease harmful events for patients.

In addition to tracking important care metrics, Regional One Health created pharmacy billing and collections databases with Domo, which included a catalog of decision support applications and dashboards to optimize operations for pharmacies within the hospital. These improvements helped cut expenses by $100,000 annually and double Regional One Health’s revenue capture rate.

“We talk a lot about multiplying impact through data and Regional One Health embodies absolutely that in their day to day work,” said Mark Maughan, SVP of customer success at Domo. “The data experience innovations they have created deliver monumental gains for the organization and most importantly, help to change lives.”

To read the full Regional One Health case study, visit here.

About Nucleus Research

Nucleus Research is the recognized global leader in ROI technology research. Using a case-based approach, we provide research streams and advisory services that allow vendors and end users to quantify and maximize the return from their technology investments. For more information, visit NucleusResearch.com or follow our latest updates on LinkedIn.

About Domo

Domo puts data to work for everyone so they can multiply their impact on the business. Our cloud-native data experience platform goes beyond traditional business intelligence and analytics, making data visible and actionable with user-friendly dashboards and apps. Underpinned by AI, data science and a secure data foundation that connects with existing cloud and legacy systems, Domo helps companies optimize critical business processes at scale and in record time to spark the bold curiosity that powers exponential business results.

For more information, visit www.domo.com. You can also follow Domo on Twitter, Facebook and LinkedIn.

Domo is a registered trademark of Domo, Inc.

Cynthia Cowen

PR@domo.com

Source: Domo

Domo, Inc. Class B

NASDAQ:DOMO

DOMO Rankings

DOMO Latest News

DOMO Stock Data

365.45M
33.00M
6.81%
68.32%
5.14%
Software - Application
Services-prepackaged Software
Link
United States of America
AMERICAN FORK